Hypertyreos

Hypertyreos is a medical condition defined by the overproduction of thyroid hormones, particularly thyroxine (T4) and triiodothyronine (T3), by the thyroid gland. This hormonal excess drives a hypermetabolic state and can affect multiple organ systems. It is the clinical presentation of hyperthyroidism and can result from several underlying causes.

The most common causes are Graves’ disease, an autoimmune disorder; toxic multinodular goiter or a toxic adenoma; and thyroiditis, which can cause a temporary spike in hormone release. Less frequent causes include excess iodine intake, certain medications, and, in rare cases, thyroid-stimulating hormone-secreting tumors. The pathophysiology typically involves increased thyroid hormone production with suppressed pituitary TSH in most cases, though TSH may be detectable in early or subclinical stages.

Symptoms and signs include weight loss with preserved or increased appetite, heat intolerance, sweating, palpitations, tachycardia, tremor, anxiety, irritability, insomnia, and fatigue. In Graves’ disease, eye changes such as exophthalmos may occur. In older adults, symptoms can be nonspecific and resemble other conditions.

Diagnosis relies on laboratory tests showing low or suppressed TSH with elevated free T4 and/or free T3. Additional tests, such as thyroid antibodies and radioactive iodine uptake, help determine the cause. Imaging, including ultrasound, may be used to assess gland structure.

Treatment aims to control hormone levels and symptoms and may include antithyroid medications (methimazole or propylthiouracil), beta-blockers for symptom relief, radioactive iodine therapy, or thyroidectomy. Management also focuses on preventing complications like atrial fibrillation and bone loss, and requires regular follow-up to monitor thyroid function. Prognosis is generally favorable with appropriate treatment, though some individuals may require ongoing therapy or experience recurrence.